Research findings, pricing news, and vendor analysis across the peptide market.
DSIP is a nine-amino-acid sleep research peptide with small human insomnia studies and a wide 2026 vendor price spread. Compare vial sizes, cost per mg, evidence, COAs, and buying checkpoints before choosing a source.
Read more →Protect the value in every vial with a practical storage plan for dry and reconstituted peptides. Compare refrigeration, freezing, light, moisture, temperature swings, and vendor labeling before buying or opening a vial.
Read more →Sermorelin pricing ranges widely, but PeptidePub currently lists a $100 per month pay-as-you-go option. Compare benefits, provider terms, vial math, and the proof to check before buying.
Read more →Visible particles, persistent cloudiness, unusual color, or damaged packaging deserve documentation and a vendor investigation before the vial moves forward. Learn what appearance can reveal, what a COA cannot prove, and how a trustworthy seller should resolve a questionable lot.
Read more →Peptide pens trade concentration control and easy price-per-mg comparison for faster setup and portability. Compare fixed versus reusable pens and lyophilized vials on total milligrams, usable volume, finished-lot testing, storage, and delivered cost before buying.
Read more →TB-500 hair-growth interest is rising, but the strongest follicle studies used full-length thymosin beta-4 rather than automatically proving results for every retail TB-500 vial. Compare the evidence, exact sequence, current price per mg, and lot-matched COA proof before buying.
Read more →HGH, CJC-1295 plus ipamorelin, and tesamorelin all engage the growth hormone axis, but they are not interchangeable purchases. Compare mechanism, human evidence, current peptide prices, COA requirements, and the best buying lane for each goal.
Read more →GHK-Cu now comes as topical serum, lyophilized vial, prefilled pen, and nasal spray, but the evidence and price transparency are not equal across formats. Compare each route on proof, convenience, concentration, and real cost before buying.
Read more →NAD+ IV drips commonly cost hundreds of dollars per session, but the NAD+ itself is only one part of the bill. Compare clinic prices by dose, current NAD+ price per mg, service fees, vendor proof, and the questions worth asking before paying.
Read more →Ipamorelin is a selective growth hormone secretagogue with clear dose-response evidence and wide buyer interest. Compare published human data, current price per mg, vial math, and the COA proof that matters before checkout.
Read more →Tesamorelin has one of the clearest visceral-fat research records in the peptide market. Compare the human evidence, current price per mg, verified discounts, vial sizes, and COA proof that matter before buying.
Read more →For aging dogs, peptides split into a grounded recovery tier (joints, gut, skin) and an experimental longevity/cognitive tier. What's supported, dosing, senior-specific safety, and how to buy.
Read more →BPC-157 is the most-used peptide in dogs — for CCL tears, hip dysplasia, and gut issues. What the research actually shows, weight-based dosing, safety rules, and how to buy from COA-tested labs.
Read more →TB-500 has the longest track record of any veterinary peptide — 20+ years of equine tendon and soft-tissue use. Uses, weight-based dosing, the competition-ban caveat, and how to buy on COA proof.
Read more →Peptide use in cats is growing for IBD, arthritis, and wounds — but cats are dosed lower than dogs and their tiny volumes are hard to measure. What's used, why cats differ, safety, and buying.
Read more →Thymosin Alpha-1 is a 28-amino-acid immune-modulation peptide with an unusually deep clinical research history. Compare current prices, human-study dosage benchmarks, vendor testing, and the COA details that matter before buying.
Read more →SS-31 and MOTS-c target different parts of the mitochondrial research lane. This guide compares separate vials with blends, current price per mg, batch-specific COA proof, and the best verified buying workflow.
Read more →A high purity result does not prove that a vial contains the labeled milligrams. This buyer guide shows how to check net content, lot matching, sample size, vendor corrections, and real cost per tested mg before checkout.
Read more →Reconstitution gets easier when buyers separate vial strength, BAC water volume, concentration, and U-100 syringe units. This guide explains the math, compares current BAC water prices, and shows what to verify before adding supplies and peptides to the same cart.
Read more →The grey peptide market rewards buyers who check proof before price and price before checkout. Use this checklist to compare COAs, vendor testing, real price per mg, and current PeptidePub deals before choosing a vial.
Read more →Epitalon, also sold as Epithalon, is the longevity and telomere-research peptide buyers compare by exact AEDG identity, vial size, COA depth, and real price per mg. This guide shows how to separate 10 mg and 50 mg value, verify proof, and check PeptidePub before checkout.
Read more →KPV is the small gut and inflammation research peptide buyers compare as a straight 10 mg vial, a KLOW component, or a Beauty Blend ingredient. This guide shows how to compare price per mg, verify exact Lys-Pro-Val identity, check COA depth, and pick the strongest vendor deal before checkout.
Read more →NAD+ is the longevity and cellular-energy buy that shoppers often compare beside peptides, but the format matters. This guide shows how to choose NAD+ vs NR vs NMN, verify the right COA, compare real price per mg, and use PeptidePub before checkout.
Read more →Retatrutide is often discussed around 12 mg, but the trials reported meaningful dose-response data across the range. Here is what the data actually showed.
Read more →MOTS-c is the mitochondrial peptide buyers compare for energy, metabolic research, and healthy-aging interest. This guide shows how to buy it by vial size, effective price per mg, exact identity, third-party COA proof, vendor transparency, and live deal math before checkout.
Read more →Melanotan II is the cosmetic melanocortin peptide buyers compare when the goal is pigmentation and tanning research, not PT-141-style libido positioning. This guide shows how to compare MT-2 by price per mg, exact identity, COA depth, vendor proof, and live deal math before checkout.
Read more →PT-141 is the libido-focused melanocortin peptide buyers compare when they want central desire and arousal signaling, not another blood-flow product. This guide shows how to compare PT-141 against melanotan II, verify COAs, calculate real price per mg, and pick the strongest vendor deal before checkout.
Read more →Semax and Selank are the two cognitive peptides buyers compare most often, but they are not the same buy. This guide shows when to choose Semax, when to choose Selank, when a blend makes sense, and how to compare price, vendor proof, COAs, and discount math before checkout.
Read more →AHK-Cu and GHK-Cu are both copper peptides, but they are not the same buy. This guide compares the hair and skin evidence, product-form checks, COA proof, price per mg, and vendor workflow before checkout.
Read more →CJC-1295 plus ipamorelin and tesamorelin both sit in the growth-hormone peptide lane, but they are not the same buy. This guide compares the mechanism, evidence, price per mg, blend checks, and vendor proof buyers should review before checkout.
Read more →GLOW and KLOW are popular skin, gut, and recovery peptide blends, but the best buy depends on component mix, COA proof, and effective price after discounts. This guide shows when a blend beats straight BPC-157, when separate vials are cleaner, and how to check PeptidePub before checkout.
Read more →BPC-157 and TB-500 are the recovery-peptide stack buyers compare first for tendon, ligament, muscle, and soft-tissue support. This guide shows how to compare benefits, separate vials vs Wolverine-style blends, COA proof, price per mg, and deal codes before checkout.
Read more →Peptide prices vary wildly because buyers are comparing different vial sizes, stack formats, testing standards, and discount rules. This guide shows how to calculate the real price per mg, verify COAs, and use deals without letting the coupon pick the vendor.
Read more →CJC-1295 and ipamorelin are one of the most searched GH-support peptide stacks, but buyers need to separate No DAC from DAC, single vials from blends, and sticker price from verified price per mg.
Read more →A peptide COA is useful only when it matches the vial, names a credible lab, shows the right tests, and helps you compare price per mg before checkout.
Read more →GHK-Cu is one of the most searched skin and recovery peptides, but buyers should compare the copper-complex form, price per mg, batch-matched COAs, and vendor testing before choosing a vial.
Read more →The best peptide vendor is not just the cheapest one. Use third-party lab results, batch-matched COAs, price-per-mg math, and deal checks to find a vendor worth buying from.
Read more →Pennsylvania buyers can compare online GLP-1 programs by all-in price, medication format, coaching, lab monitoring, pharmacy safeguards, and Pennsylvania prescriber and pharmacy checks.
Read more →Novi is the better fit if you want low all-in GLP-1 pricing, free 2-day shipping, coaching, and unlimited clinician messaging. EnhanceMD is stronger if you want low first-month entry pricing, no dose escalation fees, metabolic labs every 6 months, and specific semaglutide or tirzepatide checkout paths.
Read more →Medvi is the better fit if you want video consultations, nutrition support, provider check-ins, and a brand Wegovy path. EnhanceMD is stronger if you want predictable flat-rate compounded pricing, low first-month entry pricing, and metabolic labs every 6 months.
Read more →Wegovy injection is FDA-labeled for adolescents 12 and older with obesity, but pediatric GLP-1 care is not adult weight-loss care copied onto children. Parents should understand the age boundary, trial data, side-effect signals, growth and nutrition monitoring, and why compounded or gray-market pediatric GLP-1 use is a hard no.
Read more →There is still no FDA-approved generic Ozempic, Wegovy, Mounjaro, or Zepbound that US patients can buy in pharmacies. Tentative approvals and FDA review filings are real milestones, but they are not the same as available generic supply.
Read more →New York buyers can compare online GLP-1 programs by all-in price, provider support, lab monitoring, pharmacy safeguards, and whether the prescriber and pharmacy can legally serve New York patients.
Read more →Eden Health is the better fit if you want the lowest current Eden medication headline price and a simple membership-plus-medication model. EnhanceMD is stronger if you want predictable all-in pricing, injections only, and metabolic lab screening included.
Read more →Direct Meds is the stronger fit if you want a more clinical, support-heavy GLP-1 program with video consultations, coaching, and quarterly labs. EnhanceMD is better if you want lower semaglutide entry pricing, flat-rate dosing, and metabolic labs every 6 months.
Read more →California buyers can compare online GLP-1 programs by real monthly cost, medication format, provider support, lab monitoring, pharmacy safeguards, and whether the prescriber can legally treat California patients. The strongest pick depends on whether you want lowest semaglutide price, coaching, labs, flat medication pricing, or format flexibility.
Read more →Shed is the better fit if you want the widest GLP-1 format menu, brand-name pathways, coaching, and a 10% body-weight-loss guarantee. EnhanceMD is stronger if you want predictable flat-rate compounded GLP-1 pricing, included lab monitoring, and lower first-month entry pricing.
Read more →Florida buyers can compare online GLP-1 programs by real monthly cost, medication format, provider support, lab monitoring, and whether the prescriber and pharmacy can legally serve Florida patients.
Read more →EnhanceMD appears to be a real telehealth platform with published pricing, provider review, lab monitoring, and a claimed Trustpilot profile. Buyers should still verify the exact compounded product, pharmacy, shipping, refund terms, and clinician follow-up before paying.
Read more →Eden Health is the cleaner choice if you want a simple GLP-1 path with flat medication pricing and messaging support. Shed is stronger for coaching, more medication formats, unlimited provider appointments, and a 10% body-weight-loss guarantee.
Read more →Texas buyers can compare online GLP-1 programs by all-in price, medication format, coaching, lab monitoring, and pharmacy safeguards. The best fit depends on whether you want the lowest semaglutide price, more clinical support, or the broadest medication-format choice.
Read more →Novi is the cleaner pick if you want low all-in pricing, weekly injections, fast shipping, coaching, and month-to-month flexibility. Shed is the stronger fit if you want more medication formats, a brand-name pathway, unlimited provider visits, Pivot app support, FSA eligibility, and a 10% body-weight-loss guarantee.
Read more →SkinnyRx is the lower-friction pick if you want cheap medication-first GLP-1 access with month-to-month flexibility. EnhanceMD is the better fit if you want flat-rate dosing, included metabolic labs, and more clinical monitoring around the same compounded GLP-1 category.
Read more →The next wave of obesity drugs is moving beyond single GLP-1 therapy toward triple agonists, amylin combinations, oral pills, and longer dosing intervals. Retatrutide has the strongest late-stage weight-loss signal so far, but most pipeline drugs are still investigational and should not be treated as available alternatives to Zepbound.
Read more →Direct Meds is the stronger fit if you want a simpler clinical GLP-1 path with nurse support, all-in pricing, and fast shipping. Shed is the stronger fit if you want more medication formats, a 10% body-weight-loss guarantee, coaching, unlimited provider appointments, and a brand-name pathway.
Read more →The current evidence does not show a broad human cancer-risk increase from GLP-1 drugs, and some studies suggest lower risk for obesity-related cancers. This explainer separates thyroid-label warnings, pancreatic-cancer fears, observational signals, and what the data cannot prove.
Read more →The compounded GLP-1 market has not fully shut down, but it has shifted. This tracker shows which telehealth providers now emphasize brand or direct-pay routes, which still advertise compounded semaglutide or tirzepatide, and what FDA says buyers should verify before paying.
Read more →PeterMD is the stronger fit if you want a broader men's health platform with GLP-1s, TRT, ED, hair loss, and longevity options under one account. Medvi is the stronger fit if you want a weight-loss-focused GLP-1 program with lower semaglutide entry pricing, coaching, nutrition support, and a clearer support-heavy path.
Read more →The Medicare GLP-1 Bridge starts July 1, 2026 and can bring eligible obesity GLP-1 prescriptions to $50 per month, but only if the patient, indication, drug formulation, prior authorization, and pharmacy claim all line up. Use this checklist to prepare before launch and compare cash-pay backup options if the Bridge does not fit.
Read more →Zepbound can be covered by insurance in 2026, but coverage depends on your plan, formulary, diagnosis, prior authorization rules, and whether the plan treats obesity drugs differently from diabetes drugs. Check benefits first, then compare the Zepbound savings card, LillyDirect self-pay routes, Medicare Bridge timing, Medicaid rules, and cash-pay tirzepatide backup options.
Read more →Novi is the better fit if you want the lower all-in compounded GLP-1 entry price, simple month-to-month access, and free 2-day shipping. Medvi is the better fit if you want a more structured program with clinician review, 1:1 guidance, metabolic reporting, coaching, tablets, and brand-name membership routes.
Read more →Novi is the better fit if you want the lowest all-in compounded GLP-1 pricing with coaching and fast shipping. Direct Meds is the better fit if you want a more clinical checkout, doctor review, 503A pharmacy claims, and clearer refill support at a higher monthly price.
Read more →If your employer drops GLP-1 weight-loss coverage, first separate diabetes coverage from obesity coverage, then confirm denial reasons, appeal if documentation is missing, and compare brand self-pay or vetted telehealth cash-pay options. The fastest backup path is usually a reputable cash-pay program, but the safest choice depends on your drug, diagnosis, budget, and need for FDA-approved medication.
Read more →Peter MD is better if you want GLP-1 access alongside men's health add-ons like TRT, ED medication, hair loss, and longevity products. SkinnyRx is better if you want lower-friction compounded semaglutide or tirzepatide access with clear medication-specific plans.
Read more →Novi is the better first check if you want all-in compounded GLP-1 pricing with coaching included. SkinnyRx is better if you want a low-friction order flow, medication-specific plans, and a more self-directed experience.
Read more →Peter MD is better if you want GLP-1 access bundled with men's health options like TRT, ED, hair loss, and longevity care. Direct Meds is better if you want a weight-loss-focused GLP-1 program with nurse support and transparent monthly pricing.
Read more →SkinnyRx is the cheaper, simpler way to get semaglutide or tirzepatide; Shed costs more but adds a 10% weight-loss guarantee, the widest range of medication formats, and bundled coaching. Full pricing, fine print, and a buyer decision framework.
Read more →Retatrutide produces the largest weight loss of any drug in this class, but with a heavier, dose-dependent side effect load. Here is what the Phase 3 TRIUMPH-4 data shows on nausea, dysesthesia, discontinuation rates, and the safety questions that remain before FDA approval.
Read more →Most weight-loss peptide stacks sold online have zero combination evidence. This guide ranks popular combinations from RCT-backed co-formulations to community protocols with no human data.
Read more →Novi is the better first check for low all-in compounded GLP-1 pricing. Eden Health is better if you want a broader doctor-led marketplace with compounded and brand-name GLP-1 options, but buyers need to add the membership fee before comparing costs.
Read more →A beginner-friendly guide to GLP-1 weight-loss peptides. Learn what semaglutide, tirzepatide, and retatrutide do, realistic results, side effects, costs, safety red flags, and how to start safely.
Read more →Eden Health is usually the better first check for low-cost GLP-1 access, while Breeze Meds is stronger for no-subscription flexibility, FSA/HSA use, and oral compounded options. This comparison breaks down pricing, medication formats, safety checks, and who should choose each.
Read more →Direct Meds is the stronger pick if you want nurse support and a more guided GLP-1 program. Breeze Meds is better if you want pay-as-you-go flexibility, no subscription lock-in, and FSA/HSA-friendly ordering.
Read more →The best oral GLP-1 depends on whether you care most about weight-loss evidence, simple dosing, diabetes coverage, or cash-pay access. This guide ranks Wegovy pill, Foundayo, Rybelsus, and compounded oral paths.
Read more →Medvi is the better fit if you want coaching, dietitian-oriented support, and more structured GLP-1 care. Breeze Meds is the better fit if you want pay-as-you-go flexibility, FSA/HSA eligibility, and oral compounded options without subscription lock-in.
Read more →Zepbound is still the stronger weight-loss choice for buyers who can tolerate injections and get coverage. Foundayo is the simpler access play if you want a daily pill, lower direct-pay entry pricing, or a CVS Caremark path starting sooner.
Read more →Foundayo and the Wegovy pill are both oral GLP-1 options, but they are not interchangeable. Foundayo is the simpler daily pill with no fasting rule, while Wegovy pill has stronger semaglutide continuity, cardiovascular-label context, and clear NovoCare cash-pay pricing.
Read more →Direct Meds is the better fit if you want nurse support and a more guided GLP-1 program. SkinnyRx is usually the better first check if you want lower-cost, self-directed semaglutide or tirzepatide access.
Read more →Foundayo may cost as little as $25 with eligible commercial coverage, $50 through the Medicare GLP-1 Bridge, or about $149 to $299 through direct-pay channels. This guide explains who actually qualifies, what CVS Caremark changed, and when cash-pay GLP-1 backups still make sense.
Read more →GLP-1 drugs can slow stomach emptying, which may change how some oral medicines are absorbed. The clearest contraception warning is for tirzepatide: use non-oral contraception or add a barrier method for 4 weeks after starting and after each dose increase.
Read more →GLP-1 insurance coverage is improving in pieces, but plan rules still decide what you actually pay. This tracker explains commercial formularies, Medicare Bridge access, prior authorization, and when cash-pay telehealth backup options still matter.
Read more →CVS Caremark says Zepbound will return to its commercial formularies as an additional preferred option on October 1, 2026, while Lilly's oral GLP-1 Foundayo gets a June 1 coverage path where plans approve it. This guide explains what the change does and does not mean, how to check your own benefits, and when cash-pay or telehealth alternatives still matter.
Read more →Canadian GLP-1 savings depend on the exact drug, indication, province, insurance plan, pharmacy price, and manufacturer program. This guide shows what to check before paying for Ozempic, Wegovy, Mounjaro, or Zepbound.
Read more →Direct Meds appears to be a legitimate telehealth GLP-1 access program, but it is best for buyers who want dedicated nurse support and a more guided experience. This guide explains pricing, safety checks, compounded-medication caveats, alternatives, and who should compare cheaper providers first.
Read more →Medvi appears to be a legitimate telehealth GLP-1 access program, but it is best for buyers who want coaching, dietitian-oriented support, and provider guidance. This guide explains pricing, safety checks, compounded-medication caveats, alternatives, and who should compare cheaper providers first.
Read more →SkinnyRx appears to be a legitimate telehealth GLP-1 access program, but it is best for self-directed buyers who understand compounded-medication tradeoffs. This guide explains pricing, safety checks, complaints, alternatives, and when to compare other providers.
Read more →SkinnyRx is the better fit if you want straightforward, lower-friction GLP-1 medication access. Medvi is the better fit if you want coaching, provider check-ins, and more support around dose changes and side effects.
Read more →Eden Health is the better pick if your main goal is low-cost, low-friction GLP-1 access. Direct Meds is the better pick if you want more clinical support, nurse guidance, and a stronger care structure around the medication.
Read more →Eden Health is the better fit for lower-cost, self-directed GLP-1 access. Medvi is the better fit for buyers who want more coaching, dietitian-oriented support, and provider guidance.
Read more →Eden Health appears to be a legitimate telehealth GLP-1 platform, but it is best for value-focused cash-pay buyers who understand the difference between compounded and FDA-approved medication. This guide explains pricing, safety checks, caveats, and when to compare other providers.
Read more →Starting July 1, 2026, eligible Medicare Part D beneficiaries can access select GLP-1 obesity drugs through the Medicare GLP-1 Bridge for $50 per month. This guide explains who may qualify, what is still not covered, and how it compares with cash-pay options.
Read more →Compounded tirzepatide commonly costs about $249 to $349 per month through online programs, but the real answer depends on dose, labs, support, and whether brand-name Zepbound cash-pay vials are now the better value. This guide compares the main cost buckets and shows who each option fits.
Read more →There is no single official public approved Mounjaro provider list for weight-loss shoppers. This guide explains how to verify legitimate Zepbound and tirzepatide access, compare online providers, and avoid risky sellers before paying.
Read more →SkinnyRx is the better first check if you want clearer injectable semaglutide and tirzepatide access at lower listed starting prices, while Breeze Meds is better if you want a pay-as-you-go model, FSA/HSA eligibility, and oral compounded options. This comparison breaks down pricing, medication formats, flexibility, safety checks, and who should choose each.
Read more →The best online tirzepatide program depends on whether you prioritize lowest price, medication choice, coaching, or nurse support. This guide compares Eden Health, SkinnyRx, Medvi, and Direct Meds with buyer-focused pricing notes and decision criteria.
Read more →Medvi is the better fit if you want a lower listed starting price and dietitian-led coaching, while Direct Meds is stronger if you want dedicated nurse support and a more clinical support model. This comparison breaks down pricing, medication options, safety tradeoffs, and who should choose each.
Read more →Eden Health and SkinnyRx both offer no-frills online GLP-1 access, but they differ on pricing clarity, medication formats, support, and who they fit best. This comparison gives a buyer-focused recommendation before you sign up.
Read more →Oral semaglutide is now a real weight-loss option, but the pill has strict absorption rules, pricing caveats, and evidence limits. This guide explains Wegovy pill vs Rybelsus, OASIS 4 data, dosing friction, cost, side effects, and how it compares with injectable Wegovy and orforglipron.
Read more →Losing 40, 70, or 100 pounds on a GLP-1 does not automatically make your brain update how your body looks. The research on body image, obesity treatment, and quality of life suggests this disconnect is real, common, and worth planning for.
Read more →New studies show that people who lose weight with GLP-1 medications can be judged more harshly than people who lose weight through diet and exercise. Here is what the stigma research means for disclosure, care-seeking, and how we talk about obesity treatment.
Read more →GLP-1 medications mostly reduce fat mass, but clinical body-composition substudies show some lean mass loss is real. The practical answer is not panic, it is protein, resistance training, slower loss when appropriate, and tracking strength, not just scale weight.
Read more →One targets GLP-1 receptors. The other targets GLP-1 and GIP. Clinical trials show tirzepatide edges out semaglutide on weight loss — but the full picture is more nuanced.
Read more →Hormonal shifts after 40 make weight loss harder. GLP-1 medications can help — but the research on women specifically tells a different story than the headlines.
Read more →Most people notice appetite changes within 1-2 weeks, but meaningful weight loss takes 8-12 weeks. Here's the realistic week-by-week timeline from clinical trials.
Read more →PCOS affects 1 in 10 women and is driven by insulin resistance. GLP-1 medications target that root cause — and the early research is promising.
Read more →GLP-1s work without strict dieting — but the research shows that adding protein and resistance training dramatically improves results and prevents muscle loss.
Read more →There are dozens of online weight loss programs. Most aren't worth your money. We reviewed the ones that are — ranked by pricing, medications, and the support you actually get.
Read more →Brand-name Wegovy costs $1,350/month. Compounded semaglutide starts at $149/month online. Here's where to get it, what to look for, and what to avoid.
Read more →Same active ingredient, 80% cheaper. So what's the catch? An honest look at the differences between FDA-approved Ozempic and compounded semaglutide — and how to decide.
Read more →Brand Zepbound costs $1,069/month. Compounded tirzepatide starts around $249/month. But is it legit? Here's what real users report and what to look for.
Read more →Without insurance, brand-name GLP-1s cost $12,000–$16,000 per year. Here are real, legal ways to get the same medications for $149–$349/month — no insurance needed.
Read more →Compounded GLP-1s cost a fraction of brand-name Wegovy or Zepbound. But are they the same drug? An honest breakdown of 503A vs 503B pharmacies, what's identical, what's different, and how to decide.
Read more →Wegovy costs $1,350/month. Zepbound costs $1,069/month. Here's how to pay 50–80% less — through insurance navigation, manufacturer savings programs, compounding pharmacies, and telehealth platforms starting at $149/mo.
Read more →Starting Ozempic, Wegovy, or Mounjaro and wondering about drinking? Research shows GLP-1s significantly reduce alcohol cravings — but also change your tolerance in ways that matter practically.
Read more →Most people regain two-thirds of their lost weight within a year of stopping GLP-1 medications. Here's what the clinical trials show, why it happens biologically, and practical strategies to minimize regain.
Read more →Up to 70% of GLP-1 patients experience side effects — but most are manageable and temporary. This evidence-based guide covers what to expect at each phase of treatment and practical strategies for every common side effect.
Read more →New research from the Technical University of Munich and Harvard Medical School reveals that semaglutide and tirzepatide don't just promote weight loss — they appear to fundamentally reshape the body's metabolic and inflammatory pathways in ways researchers didn't fully anticipate.
Read more →New research from the University of Eastern Finland has found that semaglutide (Ozempic/Wegovy) is associated with significantly reduced rates of depression, anxiety, and substance use disorders — adding to a growing body of evidence that GLP-1 drugs do far more than cause weight loss.
Read more →The Trump administration announced deals with Eli Lilly and Novo Nordisk to significantly reduce the cost of weight loss medications through TrumpRx. Here's what we know and what it means for people taking semaglutide or tirzepatide.
Read more →